Inhibitory effects of interferons on pancreatic stellate cell activation

被引:20
作者
Baumert, Jan-Tido [1 ]
Sparmann, Gisela [1 ]
Emmrich, Jorg [1 ]
Liebe, Stefan [1 ]
Jaster, Robert [1 ]
机构
[1] Univ Rostock, Fac Med, Dept Med, Div Gastroenterol, D-18057 Rostock, Germany
关键词
interferons; pancreatic stellate cell; apoptosis;
D O I
10.3748/wjg.v12.i6.896
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To analyze and to compare the effects of interferon (IFN)-alpha, IFN-beta, and IFN-gamma on pancreatic stellate cell (PSC) activation in vitro and to elucidate the molecular basis of IFN action. METHODS: PSCs were isolated from rat's pancreatic tissue, cultured and stimulated with recombinant rat IFNs. Cell proliferation and collagen synthesis were assessed by measuring the incorporation of 5-bromo-2' -deoxyuridine (BrdU) into DNA and [H-3]-proline into acetic acid-soluble proteins, respectively. Apoptotic cells were determined by FACS analysis (sub-G(1) peak method). Exhibition of the myofibroblastic PSC phenotype was monitored by immunoblot analysis of alpha-smooth muscle actin (alpha-SMA) expression. To assess the activation of signal transducer and activator of transcription (STAT), Western blots using phosphoSTAT-specific antibodies were performed. In studies on STAT1 function, expression of the protein was inhibited by siRNA. RESULTS: IFN-beta and IFN-gamma, but not IFN-alpha significantly diminished PSC proliferation and collagen synthesis. IFN-gamma was the only IFN that clearly inhibited cc-SMA expression. Under the experimental conditions used I no enhanced rate of apoptotic cell death was observed in response to any IFN treatment. IFN-beta and IFN-gamma induced a strong increase of STAT1 and STAT3 tyrosine phosphorylation, while the effect of IFN-alpha was much weaker. Inhibition of STAT1 expression with siRNA was associated with a significantly reduced growth-inhibitory effect of IFN-gamma. CONCLUSION: IFN-beta and particularly IFN-gamma display inhibitory effects on PSC activation in vitro and should
引用
收藏
页码:896 / 901
页数:6
相关论文
共 33 条
[11]   MOLECULAR MECHANISMS OF LIVER FIBROGENESIS - A HOMAGE TO THE ROLE OF ACTIVATED FAT-STORING CELLS [J].
GRESSNER, AM ;
BACHEM, MG .
DIGESTION, 1995, 56 (05) :335-346
[12]   Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis [J].
Haber, PS ;
Keogh, GW ;
Apte, MV ;
Moran, CS ;
Stewart, NL ;
Crawford, DHG ;
Pirola, RC ;
McCaughan, GW ;
Ramm, GA ;
Wilson, JS .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (04) :1087-1095
[13]   CYTOKINE RECEPTOR SIGNALING [J].
IHLE, JN .
NATURE, 1995, 377 (6550) :591-594
[14]   Regulation of pancreatic stellate cell function in vitro:: biological and molecular effects of all-trans retinoic acid [J].
Jaster, R ;
Hilgendorf, I ;
Fitzner, B ;
Brock, P ;
Sparmann, G ;
Emmrich, J ;
Liebe, S .
BIOCHEMICAL PHARMACOLOGY, 2003, 66 (04) :633-641
[15]   Inhibition of pancreatic stellate cell activation by the hydroxymethylglutaryl coenzyme A reductase inhibitor lovastatin [J].
Jaster, R ;
Brock, P ;
Sparmann, G ;
Emmrich, J ;
Liebe, S .
BIOCHEMICAL PHARMACOLOGY, 2003, 65 (08) :1295-1303
[16]   Extracellular signal regulated kinases are key mediators of mitogenic signals in rat pancreatic stellate cells [J].
Jaster, R ;
Sparmann, G ;
Emmirich, J ;
Liebe, S .
GUT, 2002, 51 (04) :579-584
[17]   TGFβ1 autocrine growth control in isolated pancreatic fibroblastoid cells/stellate cells in vitro [J].
Kruse, ML ;
Hildebrand, PB ;
Timke, C ;
Fölsch, UR ;
Schmidt, WE .
REGULATORY PEPTIDES, 2000, 90 (1-3) :47-52
[18]  
LONGNECKER DS, 1982, AM J PATHOL, V107, P103
[19]   Platelet-derived growth factors stimulate proliferation and extracellular matrix synthesis of pancreatic stellate cells:: Implications in pathogenesis of pancreas fibrosis [J].
Luttenberger, T ;
Schmid-Kotsas, A ;
Menke, A ;
Siech, M ;
Beger, H ;
Adler, G ;
Grünert, A ;
Bachem, MG .
LABORATORY INVESTIGATION, 2000, 80 (01) :47-55
[20]   A c-Jun NH2-terminal kinase inhibitor SP600125 (anthra[1,9-cd]pyrazole-6 (2H)-one) blocks activation of pancreatic stellate cells [J].
Masamune, A ;
Kikuta, K ;
Suzuki, N ;
Satoh, M ;
Satoh, K ;
Shimosegawa, T .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 310 (02) :520-527